Frankfurt - Delayed Quote EUR
Ultragenyx Pharmaceutical Inc. (UP0.F)
33.40
+1.20
+(3.73%)
At close: June 13 at 8:00:54 AM GMT+2
Major Holders
Breakdown | |
---|---|
3.47% | % of Shares Held by All Insider |
98.32% | % of Shares Held by Institutions |
101.86% | % of Float Held by Institutions |
425 | Number of Institutions Holding Shares |
Top Institutional Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
Vanguard Group Inc | 10M | Mar 31, 2025 | 10.57% | 333,873,963 |
Blackrock Inc. | 6.16M | Mar 31, 2025 | 6.51% | 205,686,093 |
Sands Capital Management, LLC | 4.16M | Mar 31, 2025 | 4.40% | 139,062,943 |
Price (T.Rowe) Associates Inc | 3.22M | Mar 31, 2025 | 3.40% | 107,512,667 |
State Street Corporation | 2.62M | Mar 31, 2025 | 2.77% | 87,457,569 |
Wellington Management Group, LLP | 2.45M | Mar 31, 2025 | 2.59% | 81,813,236 |
ClearBridge Investments, LLC | 2.26M | Mar 31, 2025 | 2.39% | 75,474,150 |
Adage Capital Partners GP L.L.C. | 2.15M | Mar 31, 2025 | 2.27% | 71,776,603 |
Federated Hermes, Inc. | 2.06M | Mar 31, 2025 | 2.17% | 68,643,683 |
Suvretta Capital Management, LLC | 2.02M | Mar 31, 2025 | 2.14% | 67,618,303 |
Top Mutual Fund Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.78M | Mar 31, 2025 | 2.94% | 92,943,887 |
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.19M | Mar 31, 2025 | 2.32% | 73,153,752 |
VANGUARD EXPLORER FUND | 2M | Jan 31, 2025 | 2.12% | 66,866,302 |
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.41M | Mar 31, 2025 | 1.50% | 47,220,087 |
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.23M | Mar 31, 2025 | 1.30% | 41,114,767 |
Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund | 1.09M | Jan 31, 2025 | 1.15% | 36,439,401 |
SPDR SERIES TRUST-SPDR(R) S&P(R) Biotech ETF | 1.06M | Apr 30, 2025 | 1.12% | 35,458,343 |
Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund | 932.5k | Jan 31, 2025 | 0.99% | 31,145,501 |
T. Rowe Price Health Sciences Fund, Inc. | 892.49k | Mar 31, 2025 | 0.94% | 29,809,033 |
ACAP Strategic Fund | 826.7k | Mar 31, 2025 | 0.87% | 27,611,714 |
Related Tickers
GXEA.F Galapagos NV
24.60
+0.82%
GLPG.VI Galapagos NV
24.92
+0.81%
38I.F Intellia Therapeutics, Inc.
6.79
-9.44%
4DN.MU Denali Therapeutics Inc.
12.91
-2.23%
2L9.F Blueprint Medicines Corporation
109.00
-0.91%
26CA.F ImmunityBio, Inc.
2.6460
-3.18%
2LB.F Iovance Biotherapeutics, Inc.
1.9322
+1.19%
MRUS Merus N.V.
54.61
-1.41%
VNDA Vanda Pharmaceuticals Inc.
4.5100
-2.59%
GOVX GeoVax Labs, Inc.
1.0300
-9.65%